SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
04/09/26	₩2,295.00	+1.55%	476,974
03/09/26	₩2,260.00	-2.16%	665,896
02/09/26	₩2,310.00	+1.99%	690,240
01/09/26	₩2,265.00	-2.37%	600,713
31/08/26	₩2,320.00	-5.69%	1,287,478

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 04/09/2026			5-day change	1st Jan Change
2,295.00 ^KRW	+1.55%		-6.71%	+34.13%

09-01	Incerasolution Co., Ltd. announced that it has received KRW 13.5 billion in funding from a group of investors	CI
08-20	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI

Market Cap	138B 102M 88.19M 82.97M 75.79M 142M 9.68B 142M 980M 380M 4.96B 385M 376M 15.99B	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	145B 108M 92.77M 87.29M 79.74M 149M 10.18B 150M 1.03B 400M 5.22B 405M 396M 16.83B	EV / Sales 2025	3.42x	EV / Sales 2026	9.89x
Free-Float	75.22%	Yield 2025 *	-	Yield 2026	-

09-01	Incerasolution Co., Ltd. announced that it has received KRW 13.5 billion in funding from a group of investors	CI
08-20	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
08-13	SV Investment Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-02	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
06-18	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-30	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
05-28	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
05-21	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
05-14	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
04-14	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
02-26	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
02-13	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

1 day	+1.55%
1 week	-6.71%
Current month	-1.08%
1 month	+22.01%
3 months	-10.70%
6 months	-25.12%
Current year	+34.13%

SV Investment Corporation Stock

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation : SV Investment Corporation

Chart: SV Investment Corporation

Latest news : SV Investment Corporation

Quotes and Performance

Price Extremes

Managers and Directors : SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	2,200	2,420
1 month	1,863	2,840
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Won-Ho Hong CEO	Chief Executive Officer	61	30/09/2019
Seong-Ho Park CEO	Chief Executive Officer	57	-
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	30/06/2023

Director	Title	Age	Since
Seong-Ho Park BRD	Director/Board Member	57	-
Won-Ho Hong BRD	Director/Board Member	61	30/09/2019
Ji-Hwa Ryu BRD	Director/Board Member	56	30/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	+1.55%	-6.71%	+24.93%	+17.21%	102M
BB BIOTECH AG	-1.08%	-1.61%	+62.30%	+34.55%	3.75B
HERCULES CAPITAL, INC.	-0.51%	+0.86%	-8.98%	+7.70%	3.25B
HBM HEALTHCARE INVESTMENTS AG	+0.43%	-0.43%	+31.64%	+28.45%	1.9B
MOLTEN VENTURES PLC	+0.44%	-3.39%	+84.49%	+183.40%	1.46B
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	729M
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	+8.00%	-6.38%	+148.84%	+204.16%	591M
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.33%	-7.05%	409M
OCTOPUS TITAN VCT PLC	0.00%	0.00%	-40.68%	-75.18%	390M
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	370M
Average	+0.88%	-0.93%	+29.70%	+37.32%	1.3B
Weighted average by Cap.	+0.05%	-0.81%	+35.49%	+42.96%

	2025	2026
Net sales	19.98B 14.84M 12.77M 12.01M 10.97M 20.53M 1.4B 20.59M 142M 55.09M 719M 55.72M 54.51M 2.32B	20.52B 15.23M 13.11M 12.33M 11.27M 21.08M 1.44B 21.13M 146M 56.56M 738M 57.21M 55.96M 2.38B
Net income	-5.23B -3.89M -3.34M -3.15M -2.87M -5.38M -367M -5.39M -37.17M -14.42M -188M -14.59M -14.27M -606M	-1B -743K -640K -602K -550K -1.03M -70.19M -1.03M -7.11M -2.76M -36.01M -2.79M -2.73M -116M
Net Debt	-1.04B -773K -665K -626K -572K -1.07M -72.97M -1.07M -7.39M -2.87M -37.44M -2.9M -2.84M -121M	7.18B 5.33M 4.59M 4.32M 3.94M 7.38M 503M 7.4M 51M 19.79M 258M 20.02M 19.58M 832M